Company Xvivo Perfusion AB

Equities

XVIVO

SE0004840718

Medical Equipment, Supplies & Distribution

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Ratings for Xvivo Perfusion AB

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Stockholm Other stock markets 11:29:31 2024-04-26 am EDT			5-day change	1st Jan Change
373 ^SEK	+4.63%		+17.85%	+13.20%

Apr. 24	Nordic Shares Declined Wednesday; Svenska Handelsbnkn Ser A Fell Furthest	DJ
Apr. 24	Transcript : Xvivo Perfusion AB, Q1 2024 Earnings Call, Apr 24, 2024

Xvivo Perfusion AB is a Sweden-based medical technology company focused on developing optimized solutions for organ, tissue and cell preservation in connection with transplantation. The Company operates in two segments: Durable goods and Non-Durable goods. The Durable goods segment comprises sale and rental income from XVIVO Perfusion System (XPS) machines. The Non-Durable goods segment implies revenue from the sale of products and services that are solutions and disposable items. The Companyâs product portfolio consists of Perfadex, STEEN Solution, XPS, XPS Disposable Kit, XVIVO Lung Cannula Set, XVIVO Organ Chamber, XPS PGM Disposable Sensors and Silicone Tubing Set. The Company markets its products in Europe, Asia, Middle East, and North & South America.

Number of employees: 148

SEK in Million	2022	Weight	2023	Weight	Delta
Thoracic 64.3 %	296	71.4 %	384	64.3 %	+29.70%
Abdominal 22.4 %	71	17.1 %	134	22.4 %	+89.16%
Services 13.2 %	48	11.6 %	79	13.2 %	+64.61%

SEK in Million	2022	Weight	2023	Weight	Delta
United States 51.6 %	225	54.1 %	308	51.6 %	+37.01%
EMEA Excluding Sweden, Netherlands and Italy 21.5 %	97	23.4 %	128	21.5 %	+32.27%
Italy 9.9 %	21	5.2 %	59	9.9 %	+174.32%
Asia/Pacific and Oceania 7.1 %	19	4.5 %	42	7.1 %	+124.24%
Netherlands 5.1 %	26	6.3 %	30	5.1 %	+16.29%
North and South America, Excluding the United States 4.3 %	25	6.1 %	26	4.3 %	+0.53%
Sweden 0.7 %	2	0.4 %	4	0.7 %	+152.57%

Managers	Title	Age	Since
Christoffer Rosenblad CEO	Chief Executive Officer	49	12-08-31
Kristoffer Nordström DFI	Director of Finance/CFO	39	-
Charlotte Walldal CTO	Chief Tech/Sci/R&D Officer	57	20-09-30
Andreas Wallinder CTO	Chief Tech/Sci/R&D Officer	47	20-04-22
Lena Hagman COO	Chief Operating Officer	59	22-11-30
Jaya Tiwari PRN	Corporate Officer/Principal	37	21-11-21
Johan Holmström PRN	Corporate Officer/Principal	54	20-09-06
Anne-Li Sigvardsson PRN	Corporate Officer/Principal	-	20-04-22
Henrik Isaksson PRN	Corporate Officer/Principal	53	18-07-31
Fredrik Dalborg PRN	Corporate Officer/Principal	52	-

Members of the board	Title	Age	Since
Camilla Öberg BRD	Director/Board Member	60	16-04-30
Gösta Per Johannesson CHM	Chairman	65	-
Lars Henrikson BRD	Director/Board Member	69	19-12-31
Erik Strömqvist BRD	Director/Board Member	54	-
Lena Höglund BRD	Director/Board Member	64	19-12-31
Goran Dellgren BRD	Director/Board Member	63	21-12-31

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	31,499,470	23,664,795 ( 75.13 %)	0	75.13 %

Name	Equities	%	Valuation
BURE EQUITY AB 13.87 %	4,367,504	13.87 %	112 M kr
Fjärde AP-fonden 8.684 %	2,735,553	8.684 %	70 M kr
Swedbank Robur Fonder AB 8.121 %	2,558,000	8.121 %	66 M kr
Eccenovo AB 5.693 %	1,793,361	5.693 %	46 M kr
Premier Fund Managers Ltd. 3.676 %	1,158,040	3.676 %	30 M kr
Invesco Advisers, Inc. 3.229 %	1,017,026	3.229 %	26 M kr
Handelsbanken Fonder AB 2.585 %	814,409	2.585 %	21 M kr
Deka Investment GmbH 1.585 %	499,142	1.585 %	13 M kr
Andra AP-fonden 1.407 %	443,257	1.407 %	11 M kr
Tredje AP-fonden 1.352 %	425,849	1.352 %	11 M kr

Xvivo Perfusion AB

Mässans gata 10

412 51, Gothenburg

+46 3 17 88 21 50

http://www.xvivoperfusion.com

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

373 SEK

Average target price

408 SEK

Spread / Average Target

+9.38%

Consensus

Estimates Revisions

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
XVIVO PERFUSION AB	+13.20%	1.07B
ABBOTT LABORATORIES	-2.31%	187B
MEDTRONIC PLC	-3.20%	106B
BECTON, DICKINSON AND COMPANY	-5.04%	66.9B
DEXCOM, INC.	+0.20%	49.45B
CENCORA, INC.	+17.29%	48B
HOYA CORPORATION	+4.06%	40.84B
METTLER-TOLEDO INTERNATIONAL, INC.	+2.07%	26.48B
WEST PHARMACEUTICAL SERVICES, INC.	+2.36%	26.25B
TERUMO CORPORATION	+12.96%	24.62B

Other Medical Equipment, Supplies & Distribution